300642 透景生命
已收盘 12-20 15:00:00
资讯
新帖
简况
12月20日透景生命发布公告，其股东减持12.09万股
证券之星 · 12-20 20:01
12月20日透景生命发布公告，其股东减持12.09万股
透景生命(300642.SZ)子公司取得两项医疗器械注册证
智通财经 · 11-27
透景生命(300642.SZ)子公司取得两项医疗器械注册证
透景生命最新公告：全资子公司取得2项医疗器械注册证
证券之星 · 11-27
透景生命最新公告：全资子公司取得2项医疗器械注册证
透景生命（300642）11月14日主力资金净卖出1082.51万元
证券之星 · 11-14
透景生命（300642）11月14日主力资金净卖出1082.51万元
异动快报：透景生命（300642）11月13日9点30分触及涨停板
证券之星 · 11-13
异动快报：透景生命（300642）11月13日9点30分触及涨停板
透景生命（300642）11月12日主力资金净买入113.58万元
证券之星 · 11-12
透景生命（300642）11月12日主力资金净买入113.58万元
透景生命（300642）10月30日主力资金净卖出1139.27万元
证券之星 · 10-30
透景生命（300642）10月30日主力资金净卖出1139.27万元
透景生命(300642.SZ)发布上半年业绩，净利润2439.29万元，同比下降43.16%
智通财经网 · 10-24
透景生命(300642.SZ)发布上半年业绩，净利润2439.29万元，同比下降43.16%
盘谷医学与透景生命举行战略合作签约仪式
美港电讯 · 10-12
盘谷医学与透景生命举行战略合作签约仪式
透景生命最新公告：全资子公司申报医疗器械注册获得受理
证券之星 · 09-23
透景生命最新公告：全资子公司申报医疗器械注册获得受理
透景生命(300642.SZ)：子公司申报医疗器械注册获受理
智通财经 · 09-23
透景生命(300642.SZ)：子公司申报医疗器械注册获受理
透景生命（300642）9月12日主力资金净卖出569.93万元
证券之星 · 09-12
透景生命（300642）9月12日主力资金净卖出569.93万元
透景生命中报利润下滑超八成，股东频频减持，高盛、大摩深套其中
证券之星 · 09-11
透景生命中报利润下滑超八成，股东频频减持，高盛、大摩深套其中
透景生命（300642）9月10日主力资金净卖出294.19万元
证券之星 · 09-10
透景生命（300642）9月10日主力资金净卖出294.19万元
透景生命（300642）9月9日主力资金净买入277.94万元
证券之星 · 09-09
透景生命（300642）9月9日主力资金净买入277.94万元
A股基因检测概念拉升，冠昊生物涨停，中源协和封板，开能健康、南京新百、透景生命、国际医学放量拉升。
美港电讯 · 09-09
A股基因检测概念拉升，冠昊生物涨停，中源协和封板，开能健康、南京新百、透景生命、国际医学放量拉升。
透景生命（300642）9月6日主力资金净卖出1071.35万元
证券之星 · 09-06
透景生命（300642）9月6日主力资金净卖出1071.35万元
透景生命（300642）9月5日主力资金净买入70.76万元
证券之星 · 09-05
透景生命（300642）9月5日主力资金净买入70.76万元
A股医疗器械板块盘初拉升，冠昊生物、奥美医疗双双涨停，泰林生物涨超10%，戴维医疗、透景生命、康拓医疗等跟涨。
美港电讯 · 09-02
A股医疗器械板块盘初拉升，冠昊生物、奥美医疗双双涨停，泰林生物涨超10%，戴维医疗、透景生命、康拓医疗等跟涨。
【机构调研记录】融通基金调研TCL科技、透景生命等10只个股（附名单）
证券之星 · 08-29
【机构调研记录】融通基金调研TCL科技、透景生命等10只个股（附名单）
公司概况
公司名称：
上海透景生命科技股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-21
主营业务：
上海透景生命科技股份有限公司主营业务为自主品牌的体外诊断产品的研发、生产和销售。主要服务为肿瘤相关检测、自身免疫检测等。
发行价格：
36.10
{"stockData":{"symbol":"300642","market":"SZ","secType":"STK","nameCN":"透景生命","latestPrice":15.55,"timestamp":1734678222000,"preClose":15.28,"halted":0,"volume":2553980,"delay":0,"floatShares":138000000,"shares":163000000,"eps":0.4349,"marketStatus":"已收盘","marketStatusCode":5,"change":0.27,"latestTime":"12-20 15:00:00","open":15.24,"high":15.65,"low":15.24,"amount":39614300,"amplitude":0.0268,"askPrice":15.55,"askSize":89,"bidPrice":15.54,"bidSize":40,"shortable":0,"etf":0,"ttmEps":0.4349,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734917400000},"adr":0,"adjPreClose":15.28,"symbolType":"stock","openAndCloseTimeList":[[1734658200000,1734665400000],[1734670800000,1734678000000]],"highLimit":16.81,"lowLimit":13.75,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":163021941,"pbRate":1.65,"roa":"--","roe":"1.59%","epsLYR":0.548,"committee":-0.468208,"marketValue":2535000000,"floatMarketCap":2141000000,"peRate":35.755347,"changeRate":0.0177,"turnoverRate":0.0185,"status":0},"requestUrl":"/m/hq/s/300642/wiki","defaultTab":"wiki","newsList":[{"id":"2492412240","title":"12月20日透景生命发布公告，其股东减持12.09万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492412240","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492412240?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:01","pubTimestamp":1734696083,"startTime":"0","endTime":"0","summary":"证券之星消息，12月20日透景生命发布公告《透景生命:简式权益变动报告书》，其股东UBS AG于2024年12月19日合计减持12.09万股，占公司目前总股本的0.0741%，变动期间该股股价下跌0.26%，截止12月19日收盘报15.28元。股东增减持详情见下表：根据透景生命2024年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000038728.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","300642","BK0239","BK0046"],"gpt_icon":0},{"id":"2486844673","title":"透景生命(300642.SZ)子公司取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2486844673","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486844673?lang=zh_cn&edition=full","pubTime":"2024-11-27 18:52","pubTimestamp":1732704764,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)公告，公司全资子公司上海透景诊断科技有限公司近日取上海市药品监督管理局颁发的2项医疗器械注册证，产品名称为：乙酰左旋肉碱、氯化胆碱、γ-丁基甜菜碱、左旋肉碱和氧化三甲胺质控品(液相色谱-串联质谱法)(注册证编号：沪械注准20242400403)、乙酰左旋肉碱、氯化胆碱、γ-丁基甜菜碱、左旋肉碱和氧化三甲胺校准品(液相色谱-串联质谱法)(注册证编号：沪械注准20242400409)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1222","09997","300642","BK1583","BK1100","BK0239","BK1574","BK0046","159883","09996","BK0042"],"gpt_icon":0},{"id":"2486841493","title":"透景生命最新公告：全资子公司取得2项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2486841493","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486841493?lang=zh_cn&edition=full","pubTime":"2024-11-27 18:30","pubTimestamp":1732703410,"startTime":"0","endTime":"0","summary":"透景生命公告，公司全资子公司透景诊断于近日取得上海市药品监督管理局颁发的2项医疗器械注册证。产品包括乙酰左旋肉碱、氯化胆碱、γ-丁基甜菜碱、左旋肉碱和氧化三甲胺质控品（液相色谱-串联质谱法）和校准品（液相色谱-串联质谱法），均属于第二类体外诊断试剂。这将丰富公司在质谱和多组学分析技术平台的业务布局，完善公司心血管疾病领域的产品菜单，进一步增强体外诊断领域的综合竞争力，对未来的生产经营产生正面影响。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700031573.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300642","159883","BK1583","BK1100","BK1222","BK0042","BK0239","BK0046","09997","09996","BK1574"],"gpt_icon":0},{"id":"2483504845","title":"透景生命（300642）11月14日主力资金净卖出1082.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483504845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483504845?lang=zh_cn&edition=full","pubTime":"2024-11-14 15:27","pubTimestamp":1731569224,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月14日收盘，透景生命报收于16.7元，下跌9.88%，换手率18.95%，成交量26.09万手，成交额4.57亿元。11月14日的资金流向数据方面，主力资金净流出1082.51万元，占总成交额2.37%，游资资金净流入911.97万元，占总成交额2.0%，散户资金净流入170.54万元，占总成交额0.37%。透景生命主营业务：自主品牌的体外诊断产品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400019997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","300642","BK0239"],"gpt_icon":0},{"id":"2483862097","title":"异动快报：透景生命（300642）11月13日9点30分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2483862097","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483862097?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:36","pubTimestamp":1731461779,"startTime":"0","endTime":"0","summary":"证券之星11月13日盘中消息，9点30分透景生命触及涨停板。目前价格18.53，上涨20.01%。该股为体外诊断，医疗器械，猴痘概念概念热股，当日体外诊断概念上涨1.2%，医疗器械概念上涨0.49%，猴痘概念概念上涨0.11%。近5日资金流向一览见下表：透景生命主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300009198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0042","300642","BK0239"],"gpt_icon":0},{"id":"2482723151","title":"透景生命（300642）11月12日主力资金净买入113.58万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482723151","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482723151?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:23","pubTimestamp":1731396198,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月12日收盘，透景生命报收于15.44元，上涨2.32%，换手率7.8%，成交量10.75万手，成交额1.68亿元。11月12日的资金流向数据方面，主力资金净流入113.58万元，占总成交额0.68%，游资资金净流出229.11万元，占总成交额1.37%，散户资金净流入115.53万元，占总成交额0.69%。透景生命主营业务：自主品牌的体外诊断产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200019543.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0042","300642"],"gpt_icon":0},{"id":"2479228906","title":"透景生命（300642）10月30日主力资金净卖出1139.27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479228906","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479228906?lang=zh_cn&edition=full","pubTime":"2024-10-30 15:26","pubTimestamp":1730273191,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月30日收盘，透景生命报收于14.39元，下跌2.97%，换手率3.6%，成交量4.95万手，成交额7183.99万元。10月30日的资金流向数据方面，主力资金净流出1139.27万元，占总成交额15.86%，游资资金净流入53.53万元，占总成交额0.75%，散户资金净流入1085.74万元，占总成交额15.11%。透景生命主营业务：自主品牌的体外诊断产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000022072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300642","BK0239","BK0042"],"gpt_icon":0},{"id":"2477834826","title":"透景生命(300642.SZ)发布上半年业绩，净利润2439.29万元，同比下降43.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477834826","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477834826?lang=zh_cn&edition=full","pubTime":"2024-10-24 18:56","pubTimestamp":1729767379,"startTime":"0","endTime":"0","summary":"透景生命(300642.SZ)发布2024年第三季度报告，公司前三季度营业收入3....","market":"sh","thumbnail":"https://img.zhitongcaijing.com/astock/14.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/14.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1199047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["300642"],"gpt_icon":0},{"id":"2474833669","title":"盘谷医学与透景生命举行战略合作签约仪式","url":"https://stock-news.laohu8.com/highlight/detail?id=2474833669","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474833669?lang=zh_cn&edition=full","pubTime":"2024-10-12 21:17","pubTimestamp":1728739050,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0042","300642","BK0239","BK0046"],"gpt_icon":0},{"id":"2469316753","title":"透景生命最新公告：全资子公司申报医疗器械注册获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2469316753","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469316753?lang=zh_cn&edition=full","pubTime":"2024-09-23 16:52","pubTimestamp":1727081535,"startTime":"0","endTime":"0","summary":"透景生命公告，全资子公司江西透景生命科技有限公司申报的医疗器械注册申请于近期获得了江西省药品监督管理局的受理。产品包括凝血酶-抗凝血酶III复合物测定试剂盒等6项产品。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092300019280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09997","BK1583","BK0046","BK1100","BK1574","BK0042","BK1222","300642","BK0239","09996","159883"],"gpt_icon":0},{"id":"2469713166","title":"透景生命(300642.SZ)：子公司申报医疗器械注册获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2469713166","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469713166?lang=zh_cn&edition=full","pubTime":"2024-09-23 15:48","pubTimestamp":1727077708,"startTime":"0","endTime":"0","summary":"智通财经APP讯，透景生命(300642.SZ)公告，公司全资子公司江西透景生命科技有限公司(“江西透景”)申报的医疗器械注册申请于近期获得了江西省药品监督管理局的受理，产品名称分别为：凝血酶-抗凝血酶III复合物测定试剂盒(化学发光免疫分析法)、血栓调节蛋白测定试剂盒(化学发光免疫分析法)、纤溶酶-α2纤溶酶抑制剂复合物测定试剂盒(化学发光免疫分析法)、纤维蛋白(原)降解产物测定试剂盒(化学发光免疫分析法)、组织纤溶酶原激活物-纤溶酶原激活物抑制剂-1复合物测定试剂盒(化学发光免疫分析法)、血栓多项质控品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1185798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09997","BK0046","BK0042","BK1574","BK0239","BK1222","300642","BK1583","BK1100","09996","159883"],"gpt_icon":0},{"id":"2466824496","title":"透景生命（300642）9月12日主力资金净卖出569.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466824496","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466824496?lang=zh_cn&edition=full","pubTime":"2024-09-12 15:28","pubTimestamp":1726126114,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月12日收盘，透景生命报收于12.42元，下跌2.2%，换手率4.5%，成交量6.19万手，成交额7816.96万元。9月12日的资金流向数据方面，主力资金净流出569.93万元，占总成交额7.29%，游资资金净流出595.61万元，占总成交额7.62%，散户资金净流入1165.54万元，占总成交额14.91%。透景生命主营业务：自主品牌的体外诊断产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091200018935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","300642","BK0042"],"gpt_icon":0},{"id":"2466477423","title":"透景生命中报利润下滑超八成，股东频频减持，高盛、大摩深套其中","url":"https://stock-news.laohu8.com/highlight/detail?id=2466477423","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466477423?lang=zh_cn&edition=full","pubTime":"2024-09-11 16:46","pubTimestamp":1726044419,"startTime":"0","endTime":"0","summary":"2024年上半年，透景生命盈利双降，交出近年来最差答卷。公告显示，透景生命多个IPO前股东进行了减持。在多次减持后，多位原始股东持股比例大幅减少。然而，近三年，伴随着透景生命业绩下滑，股价持续下挫，2021年至今，透景生命累计跌幅超过60%，深度套牢了这几家外资股东。目前，透景生命的股价正处于历史低位，显著低于高盛、UBS、摩根士丹利等股东当初购入时的价格，据此估算，这些股东的持股价值已经大幅缩水。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2024091100027508.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","300642","BK0042"],"gpt_icon":0},{"id":"2466827107","title":"透景生命（300642）9月10日主力资金净卖出294.19万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466827107","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466827107?lang=zh_cn&edition=full","pubTime":"2024-09-10 15:23","pubTimestamp":1725952988,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月10日收盘，透景生命报收于12.8元，下跌2.81%，换手率6.29%，成交量8.66万手，成交额1.12亿元。9月10日的资金流向数据方面，主力资金净流出294.19万元，占总成交额2.62%，游资资金净流出726.95万元，占总成交额6.48%，散户资金净流入1021.14万元，占总成交额9.1%。透景生命主营业务：自主品牌的体外诊断产品的研发、生产和销售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024091000018612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300642","BK0042","BK0239"],"gpt_icon":0},{"id":"2466756134","title":"透景生命（300642）9月9日主力资金净买入277.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466756134","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466756134?lang=zh_cn&edition=full","pubTime":"2024-09-09 15:20","pubTimestamp":1725866407,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月9日收盘，透景生命报收于13.17元，上涨7.33%，换手率10.33%，成交量14.22万手，成交额1.89亿元。9月9日的资金流向数据方面，主力资金净流入277.94万元，占总成交额1.47%，游资资金净流出155.26万元，占总成交额0.82%，散户资金净流出122.68万元，占总成交额0.65%。透景生命主营业务：自主品牌的体外诊断产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090900013612.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0042","300642","BK0046"],"gpt_icon":0},{"id":"2466190243","title":"A股基因检测概念拉升，冠昊生物涨停，中源协和封板，开能健康、南京新百、透景生命、国际医学放量拉升。","url":"https://stock-news.laohu8.com/highlight/detail?id=2466190243","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466190243?lang=zh_cn&edition=full","pubTime":"2024-09-09 09:54","pubTimestamp":1725846860,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0113","000516","BK0188","BK0236","BK0196","300272","BK0216","BK0096","BK0070","BK0060","399300","BK0209","BK0020","BK0239","600645","600682","BK0114","BK0042","BK0086","BK0077","BK0135","BK0224","300238","BK0183","BK0150","BK0093","BK0046","159982","BK0181","300642","BK0251","BK0146"],"gpt_icon":0},{"id":"2465965184","title":"透景生命（300642）9月6日主力资金净卖出1071.35万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2465965184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465965184?lang=zh_cn&edition=full","pubTime":"2024-09-06 15:23","pubTimestamp":1725607406,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月6日收盘，透景生命报收于12.27元，下跌4.66%，换手率4.72%，成交量6.5万手，成交额8065.86万元。9月6日的资金流向数据方面，主力资金净流出1071.35万元，占总成交额13.28%，游资资金净流出675.45万元，占总成交额8.37%，散户资金净流入1746.81万元，占总成交额21.66%。透景生命主营业务：自主品牌的体外诊断产品的研发、生产和销售。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090600018536.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","300642","BK0239","BK0042"],"gpt_icon":0},{"id":"2465197755","title":"透景生命（300642）9月5日主力资金净买入70.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2465197755","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465197755?lang=zh_cn&edition=full","pubTime":"2024-09-05 15:22","pubTimestamp":1725520969,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月5日收盘，透景生命报收于12.87元，下跌3.31%，换手率5.55%，成交量7.64万手，成交额9905.0万元。9月5日的资金流向数据方面，主力资金净流入70.76万元，占总成交额0.71%，游资资金净流入114.46万元，占总成交额1.16%，散户资金净流出185.22万元，占总成交额1.87%。透景生命主营业务：自主品牌的体外诊断产品的研发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090500018523.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","BK0042","300642"],"gpt_icon":0},{"id":"2464319021","title":"A股医疗器械板块盘初拉升，冠昊生物、奥美医疗双双涨停，泰林生物涨超10%，戴维医疗、透景生命、康拓医疗等跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2464319021","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464319021?lang=zh_cn&edition=full","pubTime":"2024-09-02 09:35","pubTimestamp":1725240929,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["002950","BK1100","09996","BK0251","09997","BK0077","BK0046","688314","BK1222","300813","300314","159883","BK0042","BK0086","BK1583","159982","399300","BK1574","BK0239","300642","BK0048","300238"],"gpt_icon":0},{"id":"2463307442","title":"【机构调研记录】融通基金调研TCL科技、透景生命等10只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2463307442","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463307442?lang=zh_cn&edition=full","pubTime":"2024-08-29 08:03","pubTimestamp":1724889797,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月28日披露的机构调研信息，融通基金近期对10家上市公司进行了调研，相关名单如下：1）TCL科技 个股亮点：公司推出旗下首款LCD VR显示屏，PPI高达1512。旗下最近一年表现最佳的公募基金产品为融通中证精准医疗主题指数，最新单位净值为1.48，近一年增长60.11%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900009021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SGXZ49509284.SGD","BK0026","BK0214","SGXZ81163826.USD","BK0188","BK0152","000100","BK0030","LU1781817850.SGD","BK0086","BK0028","BK0045","BK0196","LU1580142542.USD","BK0126","BK0239","BK0046","BK0042","300642","BK0012"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2017-04-21","address":"上海市浦东新区汇庆路412号","stockEarnings":[{"period":"1week","weight":-0.0431},{"period":"1month","weight":-0.0842},{"period":"3month","weight":0.3156},{"period":"6month","weight":0.3133},{"period":"1year","weight":-0.1148},{"period":"ytd","weight":-0.1098}],"companyName":"上海透景生命科技股份有限公司","boardCode":"AI0027","perCapita":"8465股","boardName":"医药制造业","registeredCapital":"16302万元","compareEarnings":[{"period":"1week","weight":-0.007},{"period":"1month","weight":0},{"period":"3month","weight":0.2307},{"period":"6month","weight":0.1234},{"period":"1year","weight":0.154},{"period":"ytd","weight":0.1321}],"survey":" 上海透景生命科技股份有限公司主营业务为自主品牌的体外诊断产品的研发、生产和销售。主要服务为肿瘤相关检测、自身免疫检测等。","serverTime":1734890611757,"listedPrice":36.1,"stockholders":"16267人(较上一季度增加12.03%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"透景生命(300642)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供透景生命(300642)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"透景生命,300642,透景生命股票,透景生命股票老虎,透景生命股票老虎国际,透景生命行情,透景生命股票行情,透景生命股价,透景生命股市,透景生命股票价格,透景生命股票交易,透景生命股票购买,透景生命股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"透景生命(300642)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供透景生命(300642)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}